Article info

Download PDFPDF

Quality of evidence considered by Health Canada in granting full market authorisation to new drugs with a conditional approval: a retrospective cohort study

Authors

  • Joel Lexchin School of Health Policy and Management, York University, Toronto, Ontario, Canada Emergency Department, University Health Network, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Joel Lexchin; jlexchin{at}yorku.ca
View Full Text

Citation

Lexchin J
Quality of evidence considered by Health Canada in granting full market authorisation to new drugs with a conditional approval: a retrospective cohort study

Publication history

  • Received October 30, 2017
  • Revised February 22, 2018
  • Accepted April 5, 2018
  • First published April 28, 2018.
Online issue publication 
April 28, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.